GMED Klasse A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 6, 2026
$75,76
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$56,5052-Wochen-Tief
$101,4052-Wochen-Hoch
P/E (TTM)
19.5
EPS (TTM)
$3.89
Umsatz (TTM)
$3.14B
Ihre Abzeichen
52W-Spanne
$56–$101
Analystenbewertung
BUY
Kursziel
$101
P/E
19.5
ROE
11.8%
Nettogewinnmarge
17.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
GMED Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$75.76
P/E (TTM)
19.5
EPS (TTM)
$3.89
Umsatz (TTM)
$3.14B
ROE (TTM)
11.8%
52W-Spanne
$57–$101
GMED Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Globus Medical, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter6.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2.94B2016-12-31 → 2025-12-31
EPS$3.922016-12-31 → 2025-12-31
Freier Cashflow$589M2016-12-31 → 2025-12-31
Nettogewinnmarge17.0%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | GMED | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 19.55-Jahres-Durchschnitt ≈54.5 | ≈54.5 | 28.6 | Unterbewertet | |
| PEG Ratio (PEG-Ratio) | ≈0.6 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | GMED | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 20.3%5-Jahres-Durchschnitt ≈12.3% | ≈12.3% | 13.1% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 29.2%5-Jahres-Durchschnitt ≈21.3% | ≈21.3% | 13.7% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 21.0%5-Jahres-Durchschnitt ≈13.7% | ≈13.7% | 11.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 17.0%5-Jahres-Durchschnitt ≈11.4% | ≈11.4% | 9.0% | Spitzenklasse | |
| ROA (TTM) | 10.2%5-Jahres-Durchschnitt ≈6.0% | ≈6.0% | 4.6% | Spitzenklasse | |
| ROE (TTM) | 11.8%5-Jahres-Durchschnitt ≈6.6% | ≈6.6% | 8.9% | Spitzenklasse | |
| ROIC | 9.3%5-Jahres-Durchschnitt ≈5.8% | ≈5.8% | 7.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | GMED | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 4.65-Jahres-Durchschnitt ≈4.5 | ≈4.5 | 2.4 | Starke Liquidität | |
| Quick Ratio (MRQ) | 2.75-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 1.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | GMED | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 16.7%5-Jahres-Durchschnitt ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 42.2%5-Jahres-Durchschnitt ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 30.1% | · | · | · | |
| EPS YoY (EPS VjV) | 422.7%5-Jahres-Durchschnitt ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 422.3%5-Jahres-Durchschnitt ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 28.4%5-Jahres-Durchschnitt ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 31.2% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 41.4%5-Jahres-Durchschnitt ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 39.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | GMED | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.5 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 1.45-Jahres-Durchschnitt ≈1.2 | ≈1.2 | 1.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 4.85-Jahres-Durchschnitt ≈5.0 | ≈5.0 | 6.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$489.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
16.2%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $1.34 | $1.12 | 19.5% |
| 31. März 2026 | Mai 12, 2026 | $1.12 | $0.94 | 19.4% |
| 31. Dezember 2025 | $1.28 | $1.17 | 9.2% | |
| 30. September 2025 | $1.18 | $0.80 | 47.8% | |
| 30. Juni 2025 | $0.86 | $0.77 | 11.6% | |
| 31. März 2025 | $0.68 | $0.76 | -10.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| Bruttogewinnmarge % | · | · | 65.0% | · | 75.0% |
| Betriebsgewinnmarge % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| Nettoergebnis | $538M | $103M | $123M | $190M | $149M |
| Verwässerte EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.3 | 2.5 | 4.9 | · | 6.2 |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $589M | $405M | $165M | · | $219M |
Institutionelle Eigentümer (13F) 639 Einreicher · $10.4B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
639
Gehaltener Wert
$10.4B
Neue Positionen
76
Geschlossene Positionen
82
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 76 (-42 vs. Vorquartal) | 82 (+32 vs. Vorquartal) | 254 (+26 vs. Vorquartal) | 180 (0 vs. Vorquartal) | +5.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921.072.916 | 10.549.455 | 8,82% | Aktien |
| BlackRock, Inc. | $853.839.261 | 10.806.724 | 8,18% | Aktien |
| JANUS HENDERSON GROUP PLC | $656.831.032 | 7.623.095 | 6,29% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $403.546.103 | 5.107.532 | 3,86% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394.606.359 | 4.994.385 | 3,78% | Aktien |
| Invesco Ltd. | $340.515.006 | 4.309.771 | 3,26% | Aktien |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338.141.467 | 4.279.730 | 3,24% | Aktien |
| STATE STREET CORP | $293.540.630 | 3.714.029 | 2,81% | Aktien |
| Sculptor Capital LP | $237.030.000 | 3.000.000 | 2,27% | Aktien |
| JPMORGAN CHASE & CO | $230.761.440 | 2.743.850 | 2,21% | Aktien |
| Burgundy Asset Management Ltd. | $212.054.428 | 3.460.983 | 2,03% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $205.090.439 | 2.380.344 | 1,96% | Aktien |
| BANK OF MONTREAL /CAN/ | $191.638.042 | 2.425.491 | 1,83% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $187.250.224 | 2.369.310 | 1,79% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $170.151.584 | 2.153.014 | 1,63% | Aktien |
| GOLDMAN SACHS GROUP INC | $140.764.853 | 1.781.608 | 1,35% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135.630.225 | 1.716.621 | 1,30% | Aktien |
| Boston Trust Walden Corp | $124.311.253 | 1.573.361 | 1,19% | Aktien |
| Boston Partners | $122.847.510 | 1.554.990 | 1,18% | Aktien |
| Allspring Global Investments Holdings, LLC | $119.384.889 | 1.571.681 | 1,14% | Aktien |
| GENEVA CAPITAL MANAGEMENT LLC | $111.962.440 | 1.417.067 | 1,07% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101.519.633 | 1.284.896 | 0,97% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98.471.901 | 1.246.322 | 0,94% | Aktien |
| Quantinno Capital Management LP | $96.320.933 | 1.219.098 | 0,92% | Aktien |
| NORGES BANK | $89.048.300 | 1.127.051 | 0,85% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88.055.393 | 1.114.484 | 0,84% | Aktien |
| MORGAN STANLEY | $86.496.544 | 1.094.753 | 0,83% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84.736.329 | 1.072.476 | 0,81% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81.207.111 | 1.027.808 | 0,78% | Aktien |
| WELLS FARGO & COMPANY/MN | $78.742.680 | 996.617 | 0,75% | Aktien |
| Madison Avenue Partners, LP | $73.891.416 | 935.216 | 0,71% | Aktien |
| ANTIPODES PARTNERS Ltd | $71.581.796 | 905.984 | 0,69% | Aktien |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70.042.286 | 886.499 | 0,67% | Aktien |
| NORTHERN TRUST CORP | $69.578.813 | 880.633 | 0,67% | Aktien |
| AXA Investment Managers S.A. | $68.885.959 | 1.202.828 | 0,66% | Aktien |
| Global Alpha Capital Management Ltd. | $67.681.230 | 856.616 | 0,65% | Aktien |
| Vestal Point Capital, LP | $67.158.500 | 850.000 | 0,64% | Aktien |
| UBS Group AG | $65.909.432 | 834.191 | 0,63% | Aktien |
| Bank of New York Mellon Corp | $61.258.598 | 775.328 | 0,59% | Aktien |
| FMR LLC | $60.683.705 | 768.051 | 0,58% | Aktien |
| BANK OF AMERICA CORP /DE/ | $58.239.298 | 737.113 | 0,56% | Aktien |
| Stephens Investment Management Group LLC | $57.159.864 | 723.451 | 0,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $56.575.822 | 716.059 | 0,54% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $54.970.813 | 695.745 | 0,53% | Aktien |
| Clark Capital Management Group, Inc. | $54.271.890 | 686.899 | 0,52% | Aktien |
| AMERICAN CAPITAL MANAGEMENT INC | $51.599.219 | 653.072 | 0,49% | Aktien |
| ANCHOR CAPITAL ADVISORS LLC | $51.225.201 | 648.338 | 0,49% | Aktien |
| Camber Capital Management LP | $47.216.000 | 800.000 | 0,45% | Aktien |
| Capital World Investors | $46.664.254 | 590.612 | 0,45% | Aktien |
| Artemis Investment Management LLP | $45.305.914 | 573.420 | 0,43% | Aktien |
Unternehmensinsider 22 Insider · 11 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 21. Januar 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 23. Januar 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 27. Januar 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 21. Januar 2026 A | 0 | 0 | 2 | $-2.032.133 |
| Richard A Baron | Senior VP and CFO | 2. Mai 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 7. März 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 25. Februar 2026 M | 0 | 0 | 3 | $-3.441.700 |
| David C Paul | Executive Chairman | 21. Januar 2026 A | 60.417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 1. Februar 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 25. Juni 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2. Februar 2018 A | 35.217 | 0 | 0 | $0 |
| James R Tobin | Direktor | 15. September 2026 M | 0 | 0 | 1 | $-2.237.400 |
| Stephen T Zarrilli | Direktor | 18. August 2026 M | 0 | 0 | 2 | $-4.283.250 |
| David D Davidar | Direktor | 27. Juli 2026 G | 507.675 | 0 | 2 | $-4.169.000 |
| Ann D Rhoads | Direktor | 4. Juni 2026 M | 40.384 | 0 | 2 | $-818.000 |
| Dan Wolterman | Direktor | 21. Januar 2026 A | 24.025 | 0 | 0 | $0 |
| Leslie V Norwalk | Direktor | 21. Januar 2026 A | 10.419 | 0 | 2 | $-557.600 |
| Dan Lemaitre | Direktor | 21. Januar 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | Direktor | 21. Januar 2026 A | 15.578 | 0 | 0 | $0 |
| Robert Andrew Douglas | Direktor | 21. Januar 2026 A | 2.005 | 0 | 0 | $0 |
| Kurt Wheeler | Direktor | 22. Januar 2019 A | 44.319 | 0 | 0 | $0 |
| Robert Liptak | Direktor | 22. Januar 2019 A | 26.159 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 69 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,90% | 16.797 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,26% | 300.351 NS | 31. Juli 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,83% | 122.008 SH | 2. Oktober 2026 | Täglich |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,52% | 13.339 NS | 31. Juli 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,37% | 22.796 NS | 31. Juli 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 340.460 NS | 31. Juli 2026 | N-PORT |
| IHI · iShares Trust | 1,25% | 541.723 SH | 11. September 2026 | Täglich |
| RFG · Invesco Exchange-Traded Fund Trust | 0,81% | 36.501 SH | 2. Oktober 2026 | Täglich |
| MCOW · Pacer Funds Trust | 0,68% | 92 NS | 31. Juli 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,58% | 9.542 NS | 31. Juli 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,50% | 13.493 SH | 2. Oktober 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,47% | 111.810 SH | 19. August 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 20.104 NS | 31. Juli 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,32% | 23.234 NS | 31. Juli 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,30% | 16.476 SH | 2. Oktober 2026 | Täglich |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,29% | 16.839 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,28% | 35.968 SH | 11. September 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,27% | 22.533 NS | 31. Juli 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,25% | 12.456 NS | 31. Juli 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 183.180 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,24% | 1.499.816 SH | 19. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 49.674 NS | 31. Juli 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,19% | 1.664 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 57.770 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,15% | 284.148 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,13% | 65.761 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,13% | 338.547 SH | 19. August 2026 | Täglich |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,13% | 22.085 SH | 2. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 53.700 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,13% | 245.718 NS | 31. Juli 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,12% | 39.173 NS | 31. Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,11% | 59.918 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,11% | 2.596.850 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,10% | 1.300.059 SH | 19. August 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 8.946 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,10% | 103.731 NS | 31. Juli 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,10% | 10.513 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 10.277 SH | 2. Oktober 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 6.977 NS | 31. Juli 2026 | N-PORT |
| IWS · iShares Trust | 0,08% | 166.482 SH | 11. September 2026 | Täglich |
| WSML · iShares Trust | 0,08% | 6.832 SH | 11. September 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 13.036 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 458.676 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,04% | 87.854 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 2.717 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 205.429 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 20.026 SH | 2. Oktober 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,03% | 8.925 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 11.916 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,02% | 99.439 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,02% | 248.750 SH | 11. September 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 67.710 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 25.284 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,02% | 27.167 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 38.185 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.476 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,01% | 4.949 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,01% | 77.825 SH | 11. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 15.270 SH | 2. Oktober 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 145.193 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 30.738 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.596.212 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.702 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 18.804 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.508 SH | 19. August 2026 | Täglich |
| IJH · iShares Trust | · | 3.976.473 SH | 11. September 2026 | Täglich |
| IJK · iShares Trust | · | 657.157 SH | 11. September 2026 | Täglich |
| XJH · iShares Trust | · | 15.479 SH | 8. September 2026 | Täglich |
| ISCB · iShares Trust | · | 5.094 SH | 11. September 2026 | Täglich |
GMED Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 23 Analysten
KAUF
Median-Ziel
$100.00
+32,0%
4 17,4%
Starker Kauf
12 52,2%
Kauf
7 30,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
13 Analysten · 2026-10-03Mittelwert-Ziel $100.92 +33,2%
← Unter allen Zielen
Aktueller Preis $75.76
Tief$84.00
Mittelwert$100.92
Hoch$125.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,71
Einstieg
$80.54
R:R 1,71
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,92
Einstieg
$79.89
R:R 1,92
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,79
Einstieg
$82.29
R:R 1,79
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026